CRONOS GROUP INC. Proceeds from Collection of Loans Receivable
CRONOS GROUP INC. (CRON) reported Proceeds from Collection of Loans Receivable of $3.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfLoansReceivable · last filed 2026-08-06
- CRONOS GROUP INC. proceeds from collection of loans receivable for the quarter ending 2025-12-31 was $2.21M.
- CRONOS GROUP INC. proceeds from collection of loans receivable for the quarter ending 2025-09-30 was $0.00.
- CRONOS GROUP INC. proceeds from collection of loans receivable for the quarter ending 2025-06-30 was $2.85M, a 8.97% increase year-over-year.
- CRONOS GROUP INC. proceeds from collection of loans receivable for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. proceeds from collection of loans receivable for fiscal 2025 was $5.06M, a 3.58% decline from fiscal 2024.
- CRONOS GROUP INC. proceeds from collection of loans receivable for fiscal 2024 was $5.25M, a 68.80% decline from fiscal 2023.
- CRONOS GROUP INC. proceeds from collection of loans receivable for fiscal 2023 was $16.83M, a 220.83% increase from fiscal 2022.
- CRONOS GROUP INC. proceeds from collection of loans receivable for fiscal 2022 was $5.25M.
| Period end | Proceeds from Collection of Loans Receivable 3 month | Proceeds from Collection of Loans Receivable 6 month | Proceeds from Collection of Loans Receivable 9 month | Proceeds from Collection of Loans Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.48M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.21M derived: sum of 2 quarters · filed 2026-02-26 | $5.06M derived: sum of 3 quarters · filed 2026-08-06 | $5.06M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.85M derived: sum of 2 quarters · filed 2026-08-06 | $2.85M 10-Q · filed 2025-11-06 | $2.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.85M 10-Q · filed 2026-08-06 | $2.82M derived: sum of 3 quarters · filed 2026-08-06 | $2.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | -$38.00K derived: sum of 2 quarters · filed 2026-02-26 | -$46.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.57M derived: sum of 3 quarters · filed 2026-02-26 | $5.25M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.61M derived: sum of 2 quarters · filed 2025-11-06 | $5.29M 10-Q · filed 2025-11-06 | $7.97M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.30M 10-Q · filed 2025-08-07 | $7.98M derived: sum of 3 quarters · filed 2026-02-26 | $10.74M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.68M 10-Q · filed 2025-05-08 | $5.36M derived: sum of 2 quarters · filed 2026-02-26 | $8.12M derived: sum of 3 quarters · filed 2026-02-26 | $13.26M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.44M derived: sum of 2 quarters · filed 2026-02-26 | $10.58M derived: sum of 3 quarters · filed 2026-02-26 | $16.83M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.90M derived: sum of 2 quarters · filed 2024-11-12 | $14.15M 10-Q · filed 2024-11-12 | $17.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $11.39M 10-Q · filed 2024-08-08 | $14.29M derived: sum of 3 quarters · filed 2025-02-27 | $15.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $6.25M 10-Q · filed 2024-05-09 | $9.16M derived: sum of 2 quarters · filed 2025-02-27 | $9.92M derived: sum of 3 quarters · filed 2025-02-27 | $10.71M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.67M derived: sum of 2 quarters · filed 2025-02-27 | $4.46M derived: sum of 3 quarters · filed 2025-02-27 | $5.25M 10-K · filed 2025-02-27 |
| 2022-09-30 | $766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.55M derived: sum of 2 quarters · filed 2023-11-08 | $2.34M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $783.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.57M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $790.00K 10-Q · filed 2023-05-09 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2019-12-31 | -$1.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-30 | $237.00K 10-K/A · filed 2020-03-30 | ||
| 2019-09-30 | $238.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 10-K/A · filed 2020-03-30 | |||
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |